Acadian Asset Management
DCPH

Acadian Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Acadian Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-184,371
Closed -$1.71M – 1904
2022
Q1 		$1.71M Sell
184,371
-210,862
-53% -$1.79M 0.01% 698
2021
Q4 		$3.86M Buy
+395,233
New +$7.43M 0.01% 519

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Acadian Asset Management's DCPH Position: Q2 2022 in Review

Acadian Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2022, closing a stake of 184,371 shares — an estimated $1.71M sold.

Acadian Asset Management first reported a position in DCPH in Q4 2021 and held it in 2 quarters. The position peaked at $3.86M in Q4 2021. 128 funds tracked by Wall St. Rank hold DCPH as of Q2 2022.

  • Acadian Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Acadian Asset Management sold 184,371 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1.71M.
  • Acadian Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Acadian Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.86M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Acadian Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.